Skip to content

Author

X. Wang

We have 1 of 4 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Efficacy and safety of tofacitinib in polymyalgia rheumatica: a retrospective comparative study.

Tofacitinib-containing regimens were associated with improvement in PMR disease activity, and combination treatment was associated with lower prednisone exposure, support further prospective evaluation of tofacitinib as a potential glucocorticoid-sparing strategy in PMR.

X. Wang, D. Feng, L. Jia et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.